Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Recruiting · NCT06837922 · Registry updated 2025-04-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 3 | 2025-04-17 | NCT06837922 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Mabgeek Biotech.Co.Ltd | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The first affiliated hospital of guangzhou medical university | Guangzhou | China | 8 |